Chemours reported $98.0M of remaining performance obligations at 30 Sep 2026, down 46% from a year earlier and down 20% from the previous quarter. That is 0.0 years of trailing revenue already under contract. Book-to-bill last quarter: 0.98.
Net new backlog added in the latest quarter: -$24.0M.
The company reports 22% of the backlog due within the first 3 months.
Customer prepayments (contract liabilities) cover 5.1% of the backlog.
Twelve-month book-to-bill: 0.98, i.e. 0.98 of new orders for every 1 of revenue recognised.
Backlog growth minus revenue growth: -47 points — revenue is catching up with orders.
By backlog size it ranks 435th among US filers the cockpit tracks.
Chemours backlog history
Remaining performance obligations at each quarter end (bars) against trailing twelve-month revenue (line).
Amounts in USD. Source: SEC XBRL filings.
Quarter end
Backlog (RPO)
TTM revenue
Coverage
Customer prepayments
30 Sep 2026
$98.0M
$5.84B
0.0 yrs
$5.00M
30 Jun 2026
$122M
$5.80B
0.0 yrs
$8.00M
31 Mar 2026
$149M
$5.82B
0.0 yrs
$12.0M
31 Dec 2025
$180M
$5.81B
0.0 yrs
$5.00M
30 Sep 2025
$183M
$5.84B
0.0 yrs
$5.00M
30 Jun 2025
$208M
$5.85B
0.0 yrs
$7.00M
31 Mar 2025
$233M
$5.79B
0.0 yrs
$6.00M
31 Dec 2024
$272M
$5.78B
0.0 yrs
$11.0M
30 Sep 2024
$299M
$5.79B
0.1 yrs
$12.0M
Questions
What is Chemours's backlog?
Chemours reported $98.0M of remaining performance obligations at 30 Sep 2026, down 46% from a year earlier and down 20% from the previous quarter. That is 0.0 years of trailing revenue already under contract. Book-to-bill last quarter: 0.98.
About these numbers
Remaining performance obligations (RPO) are revenue a company has contracted but not yet recognised, as reported in its SEC filings (XBRL tag RevenueRemainingPerformanceObligation). Coverage = backlog ÷ trailing twelve-month revenue. Book-to-bill = (change in backlog + revenue) ÷ revenue. Conversion = revenue recognised ÷ the backlog at the start of each quarter, summed over four quarters. Counterparty values come from company filings and releases.